Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2019
Immuno-PET identifies the myeloid compartment as a key contributor to the outcome of the antitumor response under PD-1 blockadeMohammad Rashidian, Martin W LaFleur, Vincent L Verschoor, et al.Cancer Immunology, Immunotherapy : CII|December 20, 2018
A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppressionKathleen M Mahoney, Sachet A Shukla, Nikolaos Patsoukis, et al.Nature Communications|April 1, 2022
USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapyWenjun Xiong, Xueliang Gao, Tiantian Zhang, et al.Nature Communications|May 19, 2023
ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapyXiangling Xiao, Jie Shi, Chuan He, et al.Cell Research|November 12, 2025
Targeted destruction of VISTA boosts anti-tumor immunotherapyLi Chen, Xia Bu, Yishuang Sun, et al.Genome Biology|October 16, 2020
Clonal tracing reveals diverse patterns of response to immune checkpoint blockadeShengqing Stan Gu, Xiaoqing Wang, Xihao Hu, et al.Cell Research|November 12, 2025
Destruction of VISTA by TRIM25 ablation in T cells potentiates cancer immunotherapyYishuang Sun, Zijian Zhang, Haiou Li, et al.Cell Chemical Biology|September 26, 2023
Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapyHaisheng Yu, Jing Liu, Xia Bu, et al.Nature Cell Biology|August 26, 2020
Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapyYang Gao, Naoe Taira Nihira, Xia Bu, et al.Cancer Discovery|February 16, 2021
Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint BlockadeShengqing Stan Gu, Wubing Zhang, Xiaoqing Wang, et al.Pageof 4